HBV downregulates E2F5 expression and upregulates miR‐181a expression, upregulation of the miRNA downregulates E2F5 expression, induces cell growth, and may have a role in the progression of HCC (an inhibitor of HBV replication). The gene discussed is E2F5; the disease is hepatocellular carcinoma.